425: Acuren and NV5 Global Advance Merger Amid Shareholder Lawsuits

Acuren Corporation and NV5 Global, Inc. have filed a supplement to their definitive proxy statement, updating on their pending merger, including the expiration of the HSR waiting period and go-shop period, while also addressing recent shareholder demand letters and lawsuits alleging material omissions.

Summary

• A supplement to the Definitive Proxy Statement was filed by NV5 Global, Inc. and Acuren Corporation regarding their Agreement and Plan of Merger, entered into on May 14, 2025.
• The merger involves a two-step process where Ryder Merger Sub I, Inc. merges into NV5, and then the surviving NV5 merges into Ryder Merger Sub II, Inc.
• The waiting period under the HSR Act expired on July 14, 2025, at 11:59 p.m., Eastern Time.
• The 60-day go-shop period under the Merger Agreement expired on July 14, 2025, with NV5 not receiving any superior acquisition proposals.
• Acuren and NV5 currently expect to complete the Merger in August 2025, contingent on required stockholder and regulatory approvals, and other conditions.
• NV5 has received several demand letters and two lawsuits from purported stockholders (Williams v. NV5 Global, Inc., et al. and Miller v. NV5 Global, Inc., et al.) alleging material omissions and misleading disclosures in the Definitive Proxy Statement.
• NV5 denies these allegations but is providing supplemental disclosures to mitigate litigation risks without admitting liability or wrongdoing.
• Supplemental disclosures include details on confidentiality agreements with Party A (May 16, 2025) and Party B (May 17, 2025), and a revised non-binding offer from Acuren on March 12, 2025, for $23.00 per share, consisting of $10.00 cash and 1.08 shares of Acuren Common Stock.
• Baird's opinion analysis for NV5 indicated implied per share values ranging from $20.32 to $30.97 (based on Adjusted EBITDA) and $14.86 to $27.07 (based on Adjusted EBIT) from selected transactions, compared to the $23.00 per share Merger Consideration.
• Baird's Discounted Cash Flow (DCF) analysis for NV5 resulted in an implied range of $18.28 to $29.31 per share, compared to the $23.00 per share Merger Consideration.
• Baird's DCF analysis for Acuren resulted in an implied range of $7.90 to $13.15 per share, compared to the then-current price of Acuren Common Stock of $10.64 per share.
• As of the supplement date, no new agreements or substantive discussions have occurred between Acuren and NV5's named executive officers regarding post-merger compensation or employment.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. Positives include the expiration of the HSR waiting period and go-shop period without a superior offer, indicating merger progress. Negatives include the ongoing shareholder lawsuits alleging material omissions, which introduce legal and reputational risk, even if management denies the claims.

Positives

• The HSR Act waiting period for the merger expired on July 14, 2025, removing a significant regulatory hurdle.
• The 60-day go-shop period expired on July 14, 2025, without NV5 receiving a 'Superior Proposal,' suggesting the current merger agreement remains the most favorable option identified.
• The merger is still expected to be completed in August 2025, maintaining the anticipated timeline.

Negatives

• NV5 has received multiple demand letters and two lawsuits from purported stockholders alleging material omissions and misleading disclosures in the Definitive Proxy Statement.
• The lawsuits allege violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934.
• NV5 is supplementing disclosures to 'moot the claims' and 'minimize the risk, costs, burden, nuisance and uncertainties inherent in litigation,' despite believing no further disclosure is legally required.

Risks

• Stockholders of NV5 may not approve the Merger Agreement.
• Stockholders of Acuren may not approve the issuance of new shares of Acuren Common Stock in the Merger.
• A condition to closing of the Merger may not be satisfied, or either party may terminate the Merger Agreement, or the Closing might be delayed or not occur at all.
• Potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Merger.
• Diversion of management time on transaction-related issues.
• The ultimate timing, outcome, and results of integrating the operations of NV5 and Acuren.
• The effects of the business combination, including the combined company's future financial condition, results of operations, strategy, and plans.
• The ability of the combined company to realize anticipated synergies in the timeframe expected or at all.
• Changes in capital markets and the ability of the combined company to finance operations in the manner expected.
• Regulatory approval of the transaction.
• The effects of commodity prices.
• Risks related to the demand for Acuren and NV5's services.
• Operating costs and business disruption may be greater than expected following the public announcement or consummation of the Merger.

Future Outlook

Acuren and NV5 currently expect to complete the Merger in August of 2025, subject to required stockholder and regulatory approvals and the satisfaction or waiver of other conditions. The combined company's future financial condition, results of operations, strategy, and plans, along with the ability to realize anticipated synergies, are subject to various risks.

Management Comments

• NV5 believes that no further disclosure is required to supplement the Definitive Proxy Statement under applicable laws.
• Solely to moot the claims in the Demand Letters and Complaints and minimize the risk, costs, burden, nuisance and uncertainties inherent in litigation, and without admitting any liability or wrongdoing, NV5 hereby supplements the disclosures contained in the Definitive Proxy Statement.
• NV5 vigorously denies all allegations in the Demand Letters and the Complaints, including that any additional disclosure was or is required, and believes that the supplemental disclosures contained herein are immaterial.

Industry Context

The document provides valuation benchmarks for the engineering and environmental consulting industry (e.g., AECOM, Jacobs Solutions, WSP Global) and the testing, inspection, and certification industry (e.g., Bureau Veritas, SGS S.A.). The merger between NV5 and Acuren represents a consolidation within these sectors, aiming to combine capabilities and potentially achieve synergies, a common trend in mature and consolidating industries.

Comparison to Industry Standards

• NV5's implied enterprise value multiples (EV/Adjusted EBITDA, EV/Adjusted EBIT) were compared to a peer group including AECOM (EV/Adjusted EBITDA LTM 12.9x, 2025E 12.2x; EV/Adjusted EBIT LTM 14.2x, 2025E 13.4x), Jacobs Solutions Inc. (EV/Adjusted EBITDA LTM 15.0x, 2025E 13.8x; EV/Adjusted EBIT LTM 16.1x, 2025E 14.8x), and WSP Global Inc. (EV/Adjusted EBITDA LTM 16.9x, 2025E 15.1x; EV/Adjusted EBIT LTM 24.5x, 2025E 23.9x).
• The implied per share values for NV5 Common Stock based on these public company multiples ranged from $20.32 to $30.97 (Adjusted EBITDA) and $14.86 to $27.07 (Adjusted EBIT), with the Merger Consideration at $23.00 per share falling within these ranges.
• NV5's implied enterprise value multiples were also compared to recent acquisitions in the sector, such as Parsons Corporation's acquisition of BCC Engineering, LLC (EV/LTM EBITDA 13.0x), WSP Global Inc.'s acquisition of Power Engineers, Incorporated (EV/LTM EBITDA 15.2x), and Tetra Tech, Inc.'s acquisition of RPS Group plc (EV/LTM EBITDA 13.5x, EV/LTM EBIT 22.5x).
• The implied per share values for NV5 Common Stock based on these selected transactions ranged from $20.32 to $30.97 (Adjusted EBITDA) and $14.86 to $27.07 (Adjusted EBIT), with the Merger Consideration of $23.00 per share falling within these ranges.
• Acuren's valuation was compared to publicly traded testing, inspection, and certification companies like Bureau Veritas SA (EV/Adjusted EBITDA LTM 14.0x, 2025E 12.8x) and SGS S.A. (EV/Adjusted EBITDA LTM 14.3x, 2025E 13.4x).

Legal Proceedings

• Several demand letters from purported NV5 stockholders alleging material information omissions in the Definitive Proxy Statement, violating Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, and seeking NV5 books and records.
• A complaint filed on July 8, 2025, in the Supreme Court of the State of New York, County of New York, captioned Williams v. NV5 Global, Inc., et al., alleging substantially the same claims as the Demand Letters.
• A complaint filed on July 9, 2025, in the Supreme Court of the State of New York, County of New York, captioned Miller v. NV5 Global, Inc., et al., also alleging substantially the same claims.
• NV5 denies all allegations and believes the supplemental disclosures are immaterial, but provides them to moot claims and minimize litigation risk without admitting liability.

Stakeholder Impact

• Shareholders (NV5): Face a vote on the merger, are subject to the terms of the $23.00 per share consideration (cash and stock), and are involved in ongoing litigation regarding proxy statement disclosures.
• Shareholders (Acuren): Will vote on the issuance of new shares for the merger.
• Employees (NV5 & Acuren): Potential for new employment agreements or amendments for executive officers post-merger; broader employee impact from integration is a general risk.

Next Steps

• Special meeting of NV5's stockholders scheduled for July 31, 2025, to approve the Merger Agreement.
• Acuren stockholder approval is required for the issuance of new shares of Acuren Common Stock in the Merger.
• Completion of the Merger is expected in August 2025, subject to approvals and conditions.
• Potential for NV5's named executive officers to enter into new employment agreements or amendments with the combined company prior to or following the merger.

Key Dates

Keywords

Merger, Acquisition, SEC Filing, Proxy Statement, NV5 Global, Acuren Corporation, Shareholder Lawsuit, HSR Act, Go-Shop Period, Financial Analysis, Valuation, Corporate Governance, Risk Management, Engineering Consulting, Environmental Consulting, Testing Inspection Certification